Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

InCoax Networks AB (publ) announces the results of the rights issue

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES OF AMERICA, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURE.The subscription period for the new share issue in InCoax Networks AB (publ) (“InCoax” or the “Company”) with preferential rights for existing shareholders (the “Rights Issue”) was completed on November 1, 2019. The outcome of the Rights Issue, which was covered by subscription and guarantee commitments corresponding to 80

TrustShield™, Ahlstrom-Munksjö’s single-use medical fabrics for ultimate protection in the operating room, clinical environment and laboratory

AHLSTROM-MUNKSJÖ, PRESS RELEASE, NOVEMBER 6, 2019 at 2:30 P.M. EET Ahlstrom-Munksjö announces the launch of TrustShield™, a versatile portfolio of medical fabrics that can be used to provide protection against surgical lasers, chemicals and potent chemotherapy drugs. TrustShield™ products were specially designed around growing market trends. The evolution of laser technology in a surgical environment has significantly advanced as their usage has become widespread for numerous specialties. Although there are many benefits to using lasers for surgical procedures, there are also risks.

Invitation to 3Q 2019 presentation

Otello Corporation ASA is presenting its 3Q 2019 results on Wednesday, November 13, 2019, at 08:00am CET. The presentation will take place at Felix Konferansesenter, Bryggetorget 3, Oslo, Norway. A live webcast will be available at: https://otellocorp.com/ir   Petter Lade, CFO Phone: +47 91143878 E-mail: petterl@otellocorp.com   About Otello: Otello holds shares in several different businesses, including (i)AdColony which helps publishers monetize their content through advertising and advertisers reach the audiences that build value for their businesses, capitalizing on

TOMRA: SUCCESSFUL ISSUANCE OF UNSECURED BONDS

Reference is made to the Q3-presentation and announcement dated 21 October 2019 regarding contemplated bond issue. TOMRA Systems ASA has today successfully issued a total amount of NOK 1,000m in senior unsecured bonds. The transaction is split in two tranches, both were significantly oversubscribed: - 3Y FRN: NOK 400m with a coupon of 3m Nibor + 0.50 % p.a. - 5Y FRN: NOK 600m with a coupon of 3m Nibor + 0.75 % p.a. The net proceeds will be used for general corporate purposes, including refinancing of existing debt. The settlement date is 14 November 2019 and the bonds will be

Kindred - winner of Sweden´s Best Looking Office

Kindred Group is the proud winner of ‘Sweden´s Best Looking Office’. The competition puts the spotlight on companies that have successfully combined aesthetic and compelling environments with a smart and flexible working space adapted to fit the organisations specific needs. Kindred Group moved into its award-winning, purpose-built facility in April this year.Kindred Group (former Unibet Group) is the proud winner of Sweden´s Best Looking Office. A competition arranged annually by Fastighetssverige and Lokalnytt.se.  Kindred moved into their new office at Urban Escape in central Stockholm

Dicot signs Agreement for Contract Research with Pelvipharm

November 6, 2019, Uppsala, Sweden – Dicot AB (publ) (“Dicot” or the “Company”) announced today that the company has entered into a research collaboration agreement with Pelvipharm, a world-leading contract research organization (CRO) based in France. This research collaboration is focused on the identification of Libiguin’s® mechanisms of action, which is a key step towards defining the exact domain for clinical use of the drug, and to support its registration as an approved drug. Pelvipharm specializes in the field of male and female sexual dysfunctions, offering both in vivo and in

Nexam Chemical presents the third quarter for 2019 on November 12 th at 11:00 CET

Nexam Chemical will publish the interim report for the third quarter 2019 on November 12th, 2019 at 08:30 CET. The report and the presentation  will be available at the company website.In connection with the release - analysts, investors and media are hereby invited to a telephone conference and audio webcast at 11:00 CET where Johan Arvidsson, CEO will present and comment the report. The presentation will be held in Swedish via a conference call or audio webcast at https://financialhearings.com/event/11856. If you do not intend

Peab renovates and extends school in Norway

Eikeli High School in Bærum, Norway is going to be renovated and extended. Peab has been commissioned to do the work by AFK eiendom FKF and the contract is worth NOK 193 million.Peab is going to renovate around 2,100 m2 of the existing school that was built in 1960. As part of the contract Peab will also build a new 4,500 m2 school building. “Peab has invested a great deal in public projects concerning care, health, schools and education. This project is a result of our initiative and we will be building up vital experience for future projects like this one,” says Trond Ormstad, Region

Metsä Board Corporation: Managers’ transactions

Metsä Board Corporation Managers’ transactions 6 November 2019 at 12 noon EETMetsäliitto Cooperative, which is a closely associated party to Metsä Board’s chairman and two members of the Board, has acquired on 1 November Metsä Board Corporation’s B shares. Metsä Board Oyj - Managers' Transactions ____________________________________________ Person subject to the notification requirement Name: Metsäliitto Osuuskunta Position: Closely associated person (X) Legal person (1):Person Discharging Managerial Responsibilities In Issuer Name: Hämälä Ilkka Position: Member

Cimco Marine AB (publ) has completed directed share issue of SEK 17,2 million

The directed share issue in Cimco Marine AB (publ) (“Cimco”) resolved by the board of directors on 24 October 2019, as authorized by the annual general meeting on 14 May 2019, has been fully subscribed. A total of 11,451,369 shares have been subscribed for by the guarantee consortium that entered into guarantee commitments in connection with the exercise period for the warrants of series 2019:1. Through the directed share issue, Cimco receives approximately SEK 17,2 million.The new shares were issued at a subscription price of SEK 1.50 per share. The subscription price for the new shares is

NORDEN initiates share buy-back programme

ANNOUNCEMENT NO. 17 - 6 NOVEMBER 2019 The Board of Directors has decided to carry out a share buy-back of up to a total of USD 10 million (approximately DKK 67 million). The share buy-back programme is initiated pursuant to the authorisation granted to the Board of Directors, which entitles NORDEN to acquire treasury shares at a nominal value not exceeding 10% of the share capital at the market price applicable at the time of acquisition with a deviation of up to 10%. This authorisation was most recently renewed at NORDEN’s general meeting on 11 April 2019. PurposeThe purpose of the

IRLAB’s drug candidates IRL942 and IRL1009 have been granted patents in the US and Europe

IRLAB announced today that drug candidates IRL942 and IRL1009 have been granted composition of matter patents in the US and Europe from respective authorities. The preclinical drug candidates are currently undergoing preparatory steps to meet the regulatory requirements for obtaining permission to conduct clinical phase I studies. Securing the intellectual property rights is an important step in protecting the results of the company’s research and strengthens the projects’ position and commercial potential.Drug candidates IRL942 and IRL1009 stem from IRLAB’s P001 research program and are

2020 Bulkers Ltd. (2020) - Delivery of Bulk Shanghai and commencement of Charter

Hamilton, Bermuda, November 6, 2019 2020 Bulkers is pleased to announce that it today took delivery of the fourth of the eight 208,000 dwt Newcastlemax newbuildings. Two further vessels are expected to be delivered by January 2020, and the remaining two vessels are expected to be delivered by May 2020. The vessel will on November 9, 2019, commence a 11-13 month index-linked timecharter with ST Shipping, a 100% owned subsidiary of Glencore. The index-linked rate reflects a significant premium to a standard Capesize as a function of higher cargo intake and lower fuel consumption.

EQT brings in GIC as minority partner in Anticimex

· EQT brings in GIC, a large institutional investor, in a 9.9% minority stake sale in Anticimex  · With the partnership, Anticimex aims to internationalize the shareholder base and accelerate further growth and expansion in Asia  · EQT remains as controlling owner and continues to support Anticimex in becoming the global leader in preventive pest control The EQT VI fund (“EQT VI”) today announced the decision to bring in GIC as a minority partner through a 9.9% stake sale in Anticimex (“the Company”), in a transaction valuing the Company at approximately EUR 3.6 billion. GIC

Nanoform wins the CPhI Excellence in Pharma Award for Formulation

Helsinki, Finland - Nanoform an innovative medicine enabling nanotechnology company, has won the Excellence in Pharma Award for Formulation at the prestigious CPhI Pharma Awards. Receiving this highly contested prize is an acknowledgement of Nanoform’s commitment to innovation in the industry through its best-in-class CESS[®] nanonization™ technology. Nanoform has been awarded for its work helping international partners find innovative solutions for drug development and delivery. Its multi-patented nanonization processhas the ability to double the number of drug compounds reaching

Digia’s Financial Calendar and Annual General Meeting in 2020

Digia PlcStock exchange release6 November 2019 at 11:00 amDuring the year 2020, Digia Plc will publish the Financial Statement Release, two Business Reviews and Half Year Financial Report as follows: · Financial Statement Release 2019: Friday, 7 February 2020 at 8:00 · Business Review 1-3/2020: Thursday, 7 May 2020 at 8:00 · Half Year Financial Report 1-6/2020: Tuesday, 11 August 2020 at 8:00 · Business Review 1-9/2020: Friday, 30 October 2020 at 15:00 The Annual Report will be available on Digia’s home page on Friday, 21 February 2020. Digia Plc’s Annual General

Comment in relation to Vonovia’s announcement that the conditions precedent to acquire approximately 69.30% of the voting rights and appr 61.19% of the share capital in Hembla have been fulfilled

Hembla AB (publ) (“Hembla”) notes that yesterday, on 5 November 2019, Vonovia SE, through its wholly-owned subsidiary HomeStar InvestCo AB, (“Vonovia”), has announced through a press release that the conditions, including competition clearance by the Swedish Competition Authority, set out in the acquisition agreement entered into between Volvia and Vega Holdco S.à r.l. on 23 September 2019, as further described in Vonovia’s and Hembla’s respective press releases on that day, have been fulfilled. Vonovia further announces that the transaction will be fully completed shortly, and that the

Swedavia considers issue of SEK denominated hybrid bonds and green bonds

Swedavia has appointed financial advisors to investigate market conditions for issuing of hybrid bonds and of green bonds under the recently launched Swedavia Green Bond Framework.2019-11-06 NOT FOR PUBLICATION, DISTRIBUTION OR RELEASE, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE SUCH PUBLICATION, DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES. An investor meeting will be held 15 November, 2019, jointly for the two transactions. Nordea and SEB are Joint Lead

A self-evident part of the customer experience in dental care requires solid professionalism

In dental care, having sterile instruments is a key part of the customer experience. An extremely high standard of hygiene is vital. Even a slight observed shortcoming in the standard of hygiene can cause damage to the patient relationship, and the patient’s trust can be hard to regain. In the worst case, hygiene problems can endanger the health of the patient and/or medical staff.In a dental care unit, the standard of hygiene must be high enough that every patient can be treated safely, even if either the patient or the healthcare professional have a symptomless or known infectious disease.

Notice to attend the annual general meeting

The shareholders of Dustin Group AB (publ), reg. no. 556703-3062 (the "Company" or "Dustin"), are hereby invited to attend the annual general meeting, to be held on Wednesday 11 December 2019 at 3.00 p.m. (CET) at Westmanska Palatset, Holländargatan 17, in Stockholm, Sweden.REGISTRATION Shareholders who wish to attend the annual general meeting shall: · be registered in the share register maintained by Euroclear Sweden on Thursday 5 December 2019 (the so-called "record date"), and · notify the Company of their intention to attend the annual general meeting no later than Thursday

FAM AB acquires shares in Munters Group AB

FAM AB has yesterday after the close of the stock exchange acquired 12 850 000 shares, corresponding to 7% of the shares outstanding, in Munters Group AB through an accelerated bookbuilding. After the transaction FAM AB is the owner of 21,1% of the shares in Munters Group AB.– We see Munters as an attractive company with good underlying growth, globally leading market positions and a strong organization. We look forward to working together with the board of directors, management and all employees to develop Munters for the long-term, says Lars Wedenborn, CEO of FAM AB. For further

Nomination Committee appointed in Instalco AB

In accordance with the principles adopted by the general meeting in Instalco AB held on 8 May 2019, the Nomination Committee shall be comprised of the Chairman of the Board of Directors and three members appointed by the three shareholders with the largest number of votes in the company. If either of the shareholders with the largest number of votes waives their right to appoint a member, the shareholder with the next largest shareholding shall be offered the opportunity to appoint a member.The Nomination Committee ahead of the 2020 AGM comprises the following members: • Krister Hansen (

There are no items matching the current filter
There are no more items matching the current filter
Back to top